VivoSeq
Other

5-Aminolevulinic Acid

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

5-aminolevulinic Acid is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

8

clinical trials

Completed5 · 63%
Not yet recruiting2 · 25%
Unknown status1 · 13%

Clinical Trials

Trial Activity

8 trials

A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients
Not yet recruiting·—·Phase 2·NCT06907485·20 enrolled
5-AminoLevulinic Acid Aided Resection Margins in Sarcoma
Not yet recruiting·UUniversity of Colorado, Denver·Phase 1·NCT07038278·20 enrolled
5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor
Completed·—·N/A·NCT02632370·69 enrolled
Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream
Completed·JJoint Authority for Päijät-Häme Social and Health Care·Phase 4·NCT02685592·10 enrolled
Treatment With 5-AminoLEvuliNic Acid Before Cardiac Surgery
Completed·UUniversity of Oxford·Phase 2·NCT07027670·48 enrolled
Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors
Completed·UUniversität Münster·Phase 2·NCT04738162·78 enrolled
Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid
Completed·UUniversity Hospital, Akershus·Phase 1/2·NCT04164849·7 enrolled
Efficacy and Safety of Painless 5-aminolevulinic Acid Photodynamic Therapy for Moderate and Severe Acne Vulgaris
Unknown status·SShanghai Dermatology Hospital·N/A·NCT04167982·234 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)